Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adult, biomanufacturing, burn, Chancery, CHMP, comprised, conference, culminated, DGCL, director, doctrine, doubt, duty, Ebvallo, EC, fiduciary, Food, forgoing, GMP, inapplicable, inflationary, invasion, leader, leaner, lump, mark, MHRA, monotherapy, moved, multicenter, older, optimization, optimize, partnership, pediatric, PF, resonance, Retraining, Russian, uninterrupted, Worker
Removed:
conditional, confirm, denominated, Description, half, hematologic, NaN, pioneer, supporting, translation
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view